Proteomics analysis reveals IGFBP2 as a candidate diagnostic biomarker for heart failure

Matthieu Berry, Michel Galinier, Clement Delmas, Pauline Fournier, Franck Desmoulin, Annie Turkieh, Harald Mischak, William Mullen, Manon Barutaut, Luc W. Eurlings, Sandra Van Wijk, Hans-Peter Brunner-La Rocca, Celine Caubere, Javed Butler, Jerome Roncalli, Maria Francesca Evaristi, Alain Cohen-Solal, Marie-France Seronde, Roger Escamilla, Jean FerrieresFrancois Koukoui, Fatima Smih, Philippe Rouet

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)5-12
JournalInternational Journal of Cardiology - Metabolic & Endocrine
Volume6
DOIs
Publication statusPublished - Mar 2015

Keywords

  • Heart failure
  • Diagnosis
  • Biomarkers
  • Proteomics

Cite this

Berry, M., Galinier, M., Delmas, C., Fournier, P., Desmoulin, F., Turkieh, A., Mischak, H., Mullen, W., Barutaut, M., Eurlings, L. W., Van Wijk, S., Rocca, H-P. B-L., Caubere, C., Butler, J., Roncalli, J., Evaristi, M. F., Cohen-Solal, A., Seronde, M-F., Escamilla, R., ... Rouet, P. (2015). Proteomics analysis reveals IGFBP2 as a candidate diagnostic biomarker for heart failure. International Journal of Cardiology - Metabolic & Endocrine , 6, 5-12. https://doi.org/10.1016/j.ijcme.2014.11.003